Digest Network Come funziona
Network
/
Società
Ec
Non verificato

Eclipse Bioinnovations, Inc.

Di cosa scriviamo

BiotecnologiaEventiFarmaceuticaSaluteScienza

4 comunicati stampa

Guarda tutti i comunicati
26/01/2026
Software
Scienza
Sanità
Farmaceutica
Information Technology
Tecnica
Biotecnologia
Salute
Mercato azionario
Eclipsebio Acquires Terrain Bio to Expand Its End-to-End AI Platform for the Design, Manufacturing, and Validation of RNA Therapeutics
Fonte
Eclipse Bioinnovations, Inc.
Emittente
Business Wire
1.00
0
10/06/2025
Scienza
Biotecnologia
Salute
Farmaceutica
Sanità
Oncologia
Eventi
Industria
Eclipsebio Launches eVERSE™, a First-of-Its-Kind Comprehensive Portfolio of RNA-Focused Datasets for AI Model Success
Fonte
Eclipse Bioinnovations, Inc.
Emittente
Business Wire
1.00
0
03/09/2024
Oncologia
Salute
Biotecnologia
Scienza
Farmaceutica
Eventi
Industria
Eclipsebio Expands eMERGE™ Platform with eSENSE dsRNA™ for dsRNA Quantification and Localization
Fonte
Eclipse Bioinnovations, Inc.
Emittente
Business Wire
1.00
0
24/07/2024
Salute
Biotecnologia
Scienza
Farmaceutica
Eventi
Fiere
Industria
Eclipsebio Launches eMERGE™ Platform, a Cutting-Edge End-to-End Solution for the Characterization and Optimization of RNA-Based Therapeutic Products
Fonte
Eclipse Bioinnovations, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0